Copy
See below for a Monday morning overview of recent MS news
View this email in your browser
Updates from

News – Multiple Sclerosis News Today

The Web's Daily Resource for Multiple Sclerosis News

In the 05/30/2016 edition:

Share
Tweet
Share
+1
Forward
Excerpts:

#CMSC16 — Multiple Sclerosis News Today to Provide Extensive On-Site Coverage of Annual Meeting

Multiple Sclerosis News Today provides extensive on-site coverage of CMSC meetingMultiple Sclerosis News Today will provide extended on-site coverage of the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting June 1-4 at the Gaylord National Resort and Convention Center in National Harbor, Maryland, across the harbor from the nation’s capital. Our news team will be posting feature articles on presentations at the conference, exclusive video […]

The post #CMSC16 — Multiple Sclerosis News Today to Provide Extensive On-Site Coverage of Annual Meeting appeared first on Multiple Sclerosis News Today.


Read on »

Report Highlights Series of Changes Needed from Canadian Employers and Government to Improve MS Patients’ Lives

shutterstock_378771547A new report by the Conference Board of Canada’s Canadian Alliance for Sustainable Health Care (CASHC) notes that employers and the Canadian government are not giving enough support towards increasing workforce participation among patients with multiple sclerosis (MS), despite the clear benefits such support would mean to not only the well-being of individuals affected by the condition but also […]

The post Report Highlights Series of Changes Needed from Canadian Employers and Government to Improve MS Patients’ Lives appeared first on Multiple Sclerosis News Today.


Read on »

R-Pharm Group To Launch Glatirat, an Analogue of Copaxone for MS Treatment

shutterstock_212688166The Russian Ministry of Health recently granted Marketing Authorization (ЛП-003567) to R-Pharm JSC for the development of  “Glatirat” (Glatiramer acetate), a drug intended for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS) and clinically isolated syndrome. According to a press release, the registration of “Glatirat” was based on a collaboration between R-Pharm and the generics […]

The post R-Pharm Group To Launch Glatirat, an Analogue of Copaxone for MS Treatment appeared first on Multiple Sclerosis News Today.


Read on »

Sanofi Genzyme Launches vs.MS Global Campaign to Raise Awareness on MS’ Physical and Emotional Burden

shutterstock_333236804Sanofi Genzyme recently launched vs.MS, a global initiative to raise awareness of the often unspoken physical and emotional burden of relapsing multiple sclerosis (RMS) on people living with the disease and their care partners. On World MS Day yesterday, the company called on the MS community to learn more about the disease and to declare themselves vs.MS on the […]

The post Sanofi Genzyme Launches vs.MS Global Campaign to Raise Awareness on MS’ Physical and Emotional Burden appeared first on Multiple Sclerosis News Today.


Read on »

MS Australia Puts Out an Owner’s Manual for ‘MS Bike’ and Anyone Willing to Take It for a Spin

MS Society fundraiserA bicycle specially designed to mimic the symptoms of multiple sclerosis (MS) now has its own owner’s manual, and the group behind the bike’s creation is inviting anyone interested to build their own experience on the spasticity and physical discomforts so well-known to people with the disease. The manual, which is available online, was produced […]

The post MS Australia Puts Out an Owner’s Manual for ‘MS Bike’ and Anyone Willing to Take It for a Spin appeared first on Multiple Sclerosis News Today.


Read on »

Mitochon Raises $1.6M to Begin Clinical Tests of Mitochondrial Modulators for MS

mitochondrial agentsMitochon Pharmaceuticals announced the completion of a second year of financing, raising a total $1.6 million to advance its lead compound, MP101, a mitochondrial targeted neuro-protective agent, into clinical testing. The company is developing mitochondrial modulators for patients with neurodegenerative diseases ranging from Alzheimer’s and Parkinson’s to multiple sclerosis (MS). A number of studies have shown an association between mitochondrial dysfunction […]

The post Mitochon Raises $1.6M to Begin Clinical Tests of Mitochondrial Modulators for MS appeared first on Multiple Sclerosis News Today.


Read on »

Hebrew University and Aurum Ventures Team to Create a Diagnostic Blood Test for RRMS

diagnostic RRMS blood testYissum Research Development Company, an arm of Hebrew University of Jerusalem, has entered into an agreement with Aurum Ventures MKI to develop a diagnostic blood test for relapsing-remitting multiple sclerosis (RRMS) and a range of other diseases, which uses differences in DNA from dying cells found in the blood of sick individuals. DNA molecules are methylated to control the […]

The post Hebrew University and Aurum Ventures Team to Create a Diagnostic Blood Test for RRMS appeared first on Multiple Sclerosis News Today.


Read on »

New Research Center at UC San Diego to Focus on Microbiome and Immunology

collaborative researchThe University of California (UC) San Diego School of Medicine and Chiba University School of Medicine, Japan, are working together to establish a new center for immunology research, with a particular focus on the microbiome and mucosal immune responses that are known to play a crucial role in a variety of diseases, including multiple sclerosis (MS). “This agreement reflects our shared interest […]

The post New Research Center at UC San Diego to Focus on Microbiome and Immunology appeared first on Multiple Sclerosis News Today.


Read on »

JC Virus Carries a Mutation in MS Patients That Amplifies Brain Disease Known as PML

JC virus and PMLA mutation in a mouse model of the John Cunningham (JC) virus, which causes progressive multifocal leukoencephalopathy (PML), allows the virus to evade the host immune responses in people with multiple sclerosis (MS), according to a study into the mechanisms of PML. Infection with the JC virus most often passes unnoticed in healthy adults. For reasons still eluding […]

The post JC Virus Carries a Mutation in MS Patients That Amplifies Brain Disease Known as PML appeared first on Multiple Sclerosis News Today.


Read on »

Copyright © 2016 BioNews Services, LLC, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp